CHILD DEVELOPMENT PEDAGOGY

Detailed explanation-1: -(COVID-19 Vaccine, mRNA) and the EUA-authorized Pfizer-BioNTech COVID-19 Vaccine for individuals 12 years of age and older can be used interchangeably without presenting any safety or effectiveness concerns.

Detailed explanation-2: -The vial for persons 12 years of age and older has a purple cap and may have a purple border on the label. Do NOT administer vaccine with an orange cap or has an orange bordered label on the vial.

Detailed explanation-3: -Purple Cap: Monovalent Pfizer-BioNTech COVID-19 Vaccines Some vaccine storage conditions are associated with beyond-use dates and times. Providers should track these time frames. Vaccine should NOT be used after the expiration date or beyond-use date/time.

Detailed explanation-4: -COMIRNATY is now the only COVID-19 vaccine approved by the FDA as a two-dose primary series for individuals 12 years and older. An EUA for a primary series in U.S. adolescents ages 12 through 15 years was previously granted in May 2021 based on initial data from the same pivotal Phase 3 clinical trial.